A randomized controlled trial of presatovir for respiratory syncytial virus after lung transplant.

Jens GottliebFernando TorresTarik HaddadGundeep DhillonDaniel F DillingChristiane KnoopReinaldo RampollaRajat WaliaVivek AhyaRomain KesslerMarie BudevClaus NeurohrAllan R GlanvilleRobert JordanDanielle PorterMatt McKevittPolina GermanYing GuoJason W ChienTimothy R WatkinsMartin R Zamora

Published in: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation (2023)

Presatovir treatment did not significantly improve change in nasal RSV load, symptoms, or lung function in lung transplant recipients.

Keyphrases

respiratory syncytial virus
lung function
chronic obstructive pulmonary disease
cystic fibrosis
air pollution
sleep quality
depressive symptoms
combination therapy
physical activity